Acadia Healthcare Company Inc.

71.36+0.3950+0.56%Vol 129.85K1Y Perf 8.78%
Mar 22nd, 2023 14:52 DELAYED
BID71.31 ASK71.40
Open70.68 Previous Close70.96
Pre-Market- After-Market-
 - -%  - -
Target Price
90.54 
Analyst Rating
Moderate Buy 2.08
Potential %
27.49 
Finscreener Ranking
     41.05
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     42.63
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     52.57
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
30.60 
Earnings Rating
Sell
Market Cap6.52B 
Earnings Date
2nd May 2023
Alpha0.00 Standard Deviation0.13
Beta1.25 

Today's Price Range

70.2671.46

52W Range

63.2089.85

5 Year PE Ratio Range

-12.50603.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
3.65%
1 Month
-12.04%
3 Months
-14.66%
6 Months
-10.20%
1 Year
8.78%
3 Years
463.62%
5 Years
75.04%
10 Years
145.20%

TickerPriceChg.Chg.%
ACHC71.360.39500.56
AAPL161.882.60001.63
GOOG107.431.59001.50
MSFT280.426.63832.42
XOM106.89-0.1500-0.14
WFC38.45-0.0300-0.08
JNJ152.84-1.0500-0.68
FB196.640.99000.51
GE92.330.15000.16
JPM130.16-0.3900-0.30
 
ProfitabilityValueIndustryS&P 500US Markets
42.80
17.70
22.30
6.30
11.21
RevenueValueIndustryS&P 500US Markets
1.94B
21.27
-9.67
-5.38
Earnings HistoryEstimateReportedSurprise %
Q04 20220.740.70-5.41
Q03 20220.800.78-2.50
Q02 20220.770.849.09
Q01 20220.630.676.35
Q04 20210.680.67-1.47
Q03 20210.720.720.00
Q02 20210.630.7112.70
Q01 20210.450.474.44
Earnings Per EndEstimateRevision %Trend
12/2022 QR0.74-5.13Negative
12/2022 FY3.080.00-
3/2023 QR0.73-3.95Negative
12/2023 FY3.31-2.65Negative
Next Report Date2nd May 2023
Estimated EPS Next Report0.71
Estimates Count5
EPS Growth Next 5 Years %13.00
Volume Overview
Volume129.85K
Shares Outstanding91.31K
Shares Float78.16M
Trades Count4.18K
Dollar Volume9.22M
Avg. Volume680.04K
Avg. Weekly Volume654.77K
Avg. Monthly Volume812.07K
Avg. Quarterly Volume573.28K

Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock closed at 70.96 per share at the end of the most recent trading day (a 0.72% change compared to the prior day closing price) with a volume of 510.12K shares and market capitalization of 6.52B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 42800 people. Acadia Healthcare Company Inc. CEO is Debra K. Osteen.

The one-year performance of Acadia Healthcare Company Inc. stock is 8.78%, while year-to-date (YTD) performance is -13.8%. ACHC stock has a five-year performance of 75.04%. Its 52-week range is between 63.2 and 89.85, which gives ACHC stock a 52-week price range ratio of 30.60%

Acadia Healthcare Company Inc. currently has a PE ratio of 26.80, a price-to-book (PB) ratio of 2.75, a price-to-sale (PS) ratio of 3.83, a price to cashflow ratio of 20.80, a PEG ratio of 2.32, a ROA of 6.39%, a ROC of 8.04% and a ROE of 11.75%. The company’s profit margin is 11.21%, its EBITDA margin is 22.30%, and its revenue ttm is $1.94 Billion , which makes it $21.27 revenue per share.

Of the last four earnings reports from Acadia Healthcare Company Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.71 for the next earnings report. Acadia Healthcare Company Inc.’s next earnings report date is 02nd May 2023.

The consensus rating of Wall Street analysts for Acadia Healthcare Company Inc. is Moderate Buy (2.08), with a target price of $90.54, which is +27.49% compared to the current price. The earnings rating for Acadia Healthcare Company Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Acadia Healthcare Company Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Acadia Healthcare Company Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.02, ATR14 : 2.05, CCI20 : -40.12, Chaikin Money Flow : -0.09, MACD : -2.80, Money Flow Index : 47.97, ROC : -4.66, RSI : 39.31, STOCH (14,3) : 50.09, STOCH RSI : 1.00, UO : 59.27, Williams %R : -49.91), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Acadia Healthcare Company Inc. in the last 12-months were: Christopher L. Howard (Option Excercise at a value of $311 453), Christopher L. Howard (Sold 20 657 shares of value $1 685 706 ), David Duckworth (Sold 26 921 shares of value $2 170 677 ), John S. Hollinsworth (Sold 10 780 shares of value $869 730 ), William F. Grieco (Sold 5 000 shares of value $412 700 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (50.00 %)
6 (50.00 %)
6 (50.00 %)
Moderate Buy
1 (8.33 %)
1 (8.33 %)
1 (8.33 %)
Hold
4 (33.33 %)
4 (33.33 %)
4 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (8.33 %)
1 (8.33 %)
1 (8.33 %)
Summary RatingModerate Buy
2.08
Moderate Buy
2.08
Moderate Buy
2.08

Acadia Healthcare Company Inc.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

CEO: Debra K. Osteen

Telephone: +1 615 861-6000

Address: 6100 Tower Circle, Franklin 37067, TN, US

Number of employees: 42 800

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

33%67%

Bearish Bullish

56%44%

Bearish Bullish

62%38%

Bearish Bullish

59%41%

TipRanks News for ACHC

Sat, 04 Mar 2023 01:55 GMT Acadia Healthcare (ACHC) Gets a Buy from RBC Capital

- TipRanks. All rights reserved.

News

Stocktwits